# Ziprasidone in Children With Autism: A Pilot Study

> **NCT00208559** · PHASE2 · COMPLETED · sponsor: **Drexel University College of Medicine** · enrollment: 15 (actual)

## Conditions studied

- Autism

## Interventions

- **DRUG:** Ziprasidone

## Key facts

- **NCT ID:** NCT00208559
- **Lead sponsor:** Drexel University College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** 2005-06
- **Final completion:** 2006-08
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2010-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00208559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00208559, "Ziprasidone in Children With Autism: A Pilot Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00208559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
